Monopar Therapeutics
MNPR
#7537
Rank
โ‚น43.32 B
Marketcap
โ‚น6,394
Share price
-1.84%
Change (1 day)
-22.06%
Change (1 year)

Earnings for Monopar Therapeutics (MNPR)

Earnings in 2026 (TTM): -โ‚น1.65 Billion

According to Monopar Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚น1.28 Billion, an increase over its 2024 earnings that were of -โ‚น1.45 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Monopar Therapeutics from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น1.65 Billion29.07%
2025 -โ‚น1.28 Billion-11.99%
2024 -โ‚น1.45 Billion85.5%
2023 -โ‚น0.78 Billion-20.1%
2022 -โ‚น0.98 Billion15.52%
2021 -โ‚น0.85 Billion44.39%
2020 -โ‚น0.59 Billion49.23%
2019 -โ‚น0.4 Billion28.04%
2018 -โ‚น0.31 Billion-80.07%
2017 -โ‚น1.54 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚น14.47 Billion 774.98%๐Ÿ‡บ๐Ÿ‡ธ USA